Drug Potentiation of Macrophage Function

The mechanism by which macrophages kill facultative intracellular parasites is not known. A test system is described utilizing human macrophages derived from blood monocytes and the opportunistic pathogen Listeria monocytogenes. In this system, bacterial killing was impaired under hypoxic conditions. Under aerobic conditions, addition of Clofazimine (B663), a phenazine derivative effective in the treatment of human leprosy, potentiated the killing of Listeria by macrophages. Potentiation occurred at drug concentrations usually attainable in man and which are not directly injurious to the bacteria. The enhanced bactericidal activity occurred only in the presence of oxygen; the drug induced increased leukocyte oxygen consumption which was insensitive to cyanide.

[1]  M. Cline.  Bactericidal Activity of Human Macrophages: Analysis of Factors Influencing the Killing of Listeria monocytogenes , 1970, Infection and immunity.

[2]  W. Vischer.  Antimicrobial activity of the leprostatic drug 3-(p-chloranilino)-10-(p-chlorphenyl-2,10-dihydro-2-(isopropylimino)-phenazine (G 30'320, B. 663). , 1970, Arzneimittel-Forschung.

[3]  R. Lehrer,et al.  Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection. , 1969, The Journal of clinical investigation.

[4]  H. I. Zeya,et al.  Cationic Protein-Bearing Granules of Polymorphonuclear Leukocytes: Separation from Enzyme-Rich Granules , 1969, Science.

[5]  W. Vischer.  The experimental properties of G 30 320 (B 663)--a new anti-leprotic agent. , 1969, Leprosy review.

[6]  M. L. Karnovsky,et al.  Deficiency of Reduced Nicotinamide-Adenine Dinucleotide Oxidase in Chronic Granulomatous Disease , 1968, Science.

[7]  M. Cline,et al.  THE INTERACTION OF HUMAN MONOCYTES AND LYMPHOCYTES , 1968, The Journal of experimental medicine.

[8]  S. Klebanoff.  Myeloperoxidase-Halide-Hydrogen Peroxide Antibacterial System , 1968, Journal of bacteriology.

[9]  Z. Cohn,et al.  The structure and function of monocytes and macrophages. , 1968, Advances in immunology.

[10]  W. Vischer.  Antimicrobial activity of the leprostatic drug 3-(p-chloranilino)-10(p-chlorphenyl)-2,10-dihydro-2-(isopropylimino)-phenazine (G 30 320). I. Studies in vitro. , 1968, Arzneimittel-Forschung.

[11]  R. Good,et al.  Studies of the metabolic activity of leukocytes from patients with a genetic abnormality of phagocytic function. , 1967, The Journal of clinical investigation.

[12]  J. H. Quastel,et al.  Biochemical Aspects of Phagocytosis , 1961, Nature.